VIVIMUSTA
NDC 24338-270, BENDAMUSTINE HYDROCHLORIDE, injection, from Azurity Pharmaceuticals, Inc..
- Product NDC
- 24338-270
- Status
- Listed
- Labeler
- Azurity Pharmaceuticals, Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA212209
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/24338-270 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BENDAMUSTINE HYDROCHLORIDE25 mg/mL
Pharmacologic classes
Alkylating Activity [MoA]; Alkylating Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 24338-270-01 | 24338027001 | 1 VIAL, MULTI-DOSE in 1 CARTON (24338-270-01) / 4 mL in 1 VIAL, MULTI-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/4df6548f-c4ad-4eb2-a54f-19766a3d90caMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=24338-270
Use it
Look up 24338-270 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/24338-270 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 24338-270. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.